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Abstract The incidence of neurodegenerative diseases in the
developed world has risen over the last century, concomitant
with an increase in average human lifespan. A major chal-
lenge is therefore to identify genes that control neuronal health
and viability with a view to enhancing neuronal health during
ageing and reducing the burden of neurodegeneration.
Analysis of gene expression data has recently been used to
infer gene functions for a range of tissues from co-expression
networks. We have now applied this approach to
transcriptomic datasets from the mammalian nervous system
available in the public domain. We have defined the genes
critical for influencing neuronal health and disease in different
neurological cell types and brain regions. The functional con-
tribution of genes in each co-expression cluster was validated
using human disease and knockout mouse phenotypes,
pathways and gene ontology term annotation. Additionally a
number of poorly annotated genes were implicated by this
approach in nervous system function. Exploiting gene expres-
sion data available in the public domain allowed us to validate
key nervous system genes and, importantly, to identify additional
genes with minimal functional annotation but with the same
expression pattern. These genes are thus novel candidates for
a role in neurological health and disease and could now be
further investigated to confirm their function and regulation
during ageing and neurodegeneration.
Keywords Mice . Neurological mutants . Neurological
disorders . Transcriptome . Gene expression profiling
Introduction
The average lifespan of individuals in the developed world
has increased dramatically over the last century, as deaths
from trauma and infection have declined. The incidence of
neurodegenerative diseases associated with ageing, including
dementia, has risen concomitantly, bringing significant social
and economic costs. However, our understanding of genetic
factors controlling nervous system form and function in health
and disease is far from complete. Thus, the identification of
genes that control neuronal health, and elucidation of core
molecular interactions that could ultimately be exploited for
the development of novel therapeutic interventions, remains a
major challenge.
A large proportion of genes in animals are involved in the
development, differentiation, maintenance and functioning of
the nervous system. For example, in Drosophila, 11% of an-
notated and predicted genes showed a specific neurological
phenotype upon knockdown [1] with 336 showing a strong
phenotype and 2106 showing moderate to weak phenotypes.
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Human s w i t h c h r omo soma l m i c r o d e l e t i o n o r
microduplication syndromes (also known as contiguous gene
syndromes) frequently experience intellectual disability, indi-
cating both the complexity of the pathways and the density of
genes for neuronal development in the human genome [2, 3].
The nervous system shows a high level of transcriptional di-
versity. Approximately 80% of all transcripts are expressed in
mammalian brain [4–7]. In one study [8], adult human brain
regions expressed more than twice as many different tran-
scripts as pancreas. Understanding the functions and interac-
tions of the different genes expressed by cell types within the
nervous system is critical if the key genetic networks modu-
lating form and function of the mammalian nervous system
are to be clarified, but many of the genes are unknown or
poorly annotated and there is little idea of their function, spec-
ificity or importance.
Analysis of mouse and human immune and connective
tissue gene expression data has been used previously to infer
gene functions of novel genes from co-expression networks
[9–14]. Numerous datasets documenting the transcriptome of
the mammalian nervous system are also available.
Importantly, these have revealed the complexity of networks
regulating health of the nervous system and implicate roles for
the wide variety of supporting (glial) cell types [15–18] in-
cluding astrocytes, oligodendrocytes, microglia and connec-
tive tissue cells that make up the majority of cells in the human
brain [19]. We now present an analysis of combined datasets
of transcription in mouse tissues, revealing key genes and
networks present in the mammalian nervous system, and re-
view the literature concerning nervous system cell type-
specific genetic markers. We identify previously unknown
genes involved in regulating neuronal form and/or function
which provide new targets for defining critical pathways that
sustain nervous system health.
Materials and methods
Gene expression analysis
Public domain microarray experiments that used the
Affymetrix MOE-430 microarray platform were identified
in GEO DataSets (http://www.ncbi.nlm.nih.gov/gds/). A
list of the datasets used in the analysis is provided in
Online Resource 1. All samples were from male C57BL/
6 mice at 8–10 weeks, except where stated. The raw data
(.cel) files were downloaded from GEO DataSets. Quality
control, normalization and probe annotation (using the
most recent annotation file from Affymetrix, dated 7
October 2014) were performed using the RMA procedure
[20] within the Affymetrix Expression Console software
package [21]. The merged intensity file was then prepared
for analysis by the network analysis tool BioLayout
Express3D. Where there were multiple samples from the
same experiment, the normalized values were averaged.
Probes showing low average expression (where no sample
reached an intensity of ≥100 for that probe) were removed
from the analysis. The dataset containing the results for the
remaining probe sets was saved as a ‘.expression’ file con-
taining a unique identifier for each row of data (in this
case, gene symbol concatenated to probe set ID), followed
by columns of gene annotations and finally, natural-scale
normalized data values for each sample, each column of
data being the averaged values derived from a different cell
or tissue type.
This file was then loaded into BioLayout Express3D [21]
and a Pearson correlation matrix calculated for each pair of
probe sets on the array. A probe-to-probe analysis was
performed. The network graph was laid out using a modi-
fied Fruchterman-Rheingold algorithm [22] in 3-
dimensional space in which nodes representing probe sets
are connected by weighted, undirected edges representing
correlations between expression patterns above the select-
ed threshold. A correlation cutoff of r = 0.9 was used to
construct a graph containing 17,111 nodes (probe sets) and
1,836,241 edges (correlations ≥0.9). The resultant graph
was large and highly structured (Fig. 1a) consisting of
one large component of 12,912 nodes and >1500 smaller
components (unconnected networks of correlations) of be-
tween 2 and 28 nodes. The topology of the graph contained
localized areas of high connectivity and high correlation
(representing groups of genes with similar profiles), deter-
mined using the Markov clustering algorithm (MCL) [23],
which has been demonstrated to be one of the most effec-
tive graph-based clustering algorithms available [24]. An
MCL inflation value of 2.2 was used as the basis for deter-
mining the granularity of clustering, as it has been shown
to be optimal when working with highly structured expres-
sion graphs [21]. The minimum cluster size was five nodes.
Clusters of greatest similarity in terms of expression were
physically close to each other in the network graph.
Clusters were numbered according to the number of nodes
they contained, the largest cluster being designated
Cluster001, and manually annotated based on the tissue(s)
with greatest mean expression of probes in the cluster. A
cluster was said to show tissue-specific expression for the
designated tissue if the average expression of genes in the
cluster in that tissue was fivefold of that in other tissues.
To validate the clusters, three additional analyses were
performed, using promoter-based expression data for
mouse from the FANTOM5 project, microarray data for
pig available from BioGPS (http://biogps.org.org) and the
initial data set supplemented by results for hippocampus
from mice treated with the prion ME7. Details of these
analyses are provided in supplementary methods (Online
Resource 2).
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Gene function
Twenty-six expression clusters were chosen for further evalu-
ation: 2 for validation and a further 24 for examination of gene
expression in different cell types and/or regions of the nervous
system. Pathway analysis was performed using Ingenuity
Pathway Analysis (IPA) software [25] (http://www.
ingenuity.com/products/IPA). All genes in these clusters
were assessed for murine and human phenotypes using
MouseMine (http://www.mousemine.org/mousemine/begin.
do) [26]. For murine models, we included data for all
genetic backgrounds. To prevent inconsistencies due to
incomplete gene knockout, we restricted our analyses to
those phenotypes associated with homozygous knockout/
null mutations only. The p values were calculated using
Bonferroni test correction against the background population
with a maximum p value of 0.05 taken as significant. It must
be noted that some genes are intensely studied and many
knockout mouse models have been generated, which could
potentially overinflate the statistics.
Classification of gene annotation
Gene ontology (GO) terms [27] were included in the normal-
ized annotated file retrieved from the Affymetrix Expression
Console. Three categories were included: GO biological pro-
cess, GO molecular function and GO cellular component. To
assess the level of annotation for each cluster, each gene in the
cluster was scored either 0 or 1 for each GO category depend-
ing on the presence (no matter how minimal) or absence of
gene ontology information. An average score weighted by the
size of the cluster was calculated for each cluster (maximum
score of 3, if each GO category had an entry for each gene in
the cluster).
Results
Clustering of the mouse transcriptome reveals
tissue-specific expression patterns
Using the vast amount of data in the public domain, we aimed
to define genes critical for influencing neuronal health and
viability. We have reanalyzed 135 mouse microarray datasets
from eight independent experiments. The pooled datasets rep-
resent 64 different tissue/cell types, including various brain
regions, spinal cord, ganglia, astrocytes, isolated neurons, em-
bryonic head and cell types from other organ systems (Online
Resource 1). These datasets were all derived using the
Affymetrix MOE-430 platform and all from male C57BL/6
mice at 8–10 weeks, unless stated (Online Resource 1). Gene
expression patterns were clustered using the network analysis
tool BioLayout Express3D to explore the relationships of the
different cell and tissue types in the analysis [28]. The impor-
tance of analysis by BioLayout Express3D is that it clusters
nodes based solely on statistical correlations of gene expres-
sion patterns and makes no assumptions about relationships
between genes. Therefore, unlike many other approaches, it
does not rely on published data on networks or known regu-
latory pathways and uses an unsupervised and model-free
approach to cluster biologically derived data, in this case,
normalized expression intensity levels derived from microar-
rays, which can highlight relationships that would otherwise
be unsuspected. The algorithms underlying BioLayout
Express3D have been explained in detail previously [21, 28].
The major element of the network graph of the probe-to
probe analysis (performed as described in ‘Methods’) is
displayed in Fig. 1a. The MCL clustering algorithm allocated
similarly expressed genes to specific clusters [29] (different
coloured nodes in Fig. 1a). The graph was explored extensive-
ly in order to understand the significance of the gene clusters
and the differential gene expression patterns across the neuro-
logical tissues sampled. We determined the most common
biological roles associated with genes in each Biolayout
Express3D cluster to enable comparison of different neuronal
cell and tissue types. We performed detailed analyses of each
cluster for higher-order canonical pathway analysis (IPA), as-
sociated human diseases (MouseMine using data available
from Online Mendelian Inheritance in Man (OMIM)) and
knockout mouse phenotype (MouseMine using data available
from Mouse Genome Informatics (MGI)). The unique genes
present in each cluster are listed in Online Resource 3. A
summary of phenotypes associated with the genes within the
clusters is presented in Table 1 and full details of human dis-
ease and knockout mouse phenotype are provided in Online
Resources 4 and 5, respectively.
It was important to establish that the clustering approach
grouped together genes of similar function. We therefore first
analysed two clusters where the highest gene expression was
in tissues other than nervous system cell types. Cluster001, the
largest cluster identified by BioLayout Express3D, contained
1627 genes. These genes were strongly expressed in the testis
with low expression in all other tissue types. IPA revealed that
375 genes have previously been associated with diseases af-
fecting the reproductive system. One hundred and three genes
have been associated with human disease including ciliary
dyskinesia and spermatogenic failure and knockout mouse
phenotype ontology enrichment reported abnormal male re-
productive system physiology. Thus, the clustering analysis
has grouped genes associated with reproduction, consistent
with the high expression in testis. Cluster014 showed highest
expression in heart, skeletal muscle and brown adipose tis-
sues, and moderate expression in nervous system tissues. It
contained 87 genes, many encoding members of each of the
mitochondrial respiratory chain complexes. IPA of this cluster
identified a network of genes related to oxidative
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Fig. 1 Network visualization and clustering of gene expression patterns.
a Network graph of the main element, showing genes (spheres) and
correlations between them of r ≥ 0.9 (grey lines). Nodes in clusters of
genes with similar expression patterns as determined by the MCL
clustering algorithm (inflation value 2.2) are shown in the same colour.
Replicates were averaged before clustering. b Network graph showing
only the clusters used for validation (testis, mitochondria) and nervous
system clusters. Histograms surrounding the network graph show the
average expression patterns of each cluster or group of related clusters.
Nervous system shows average expression of six clusters; Dorsal root
ganglia shows average of three clusters; Cerebellum and nucleus
accumbens/dorsal striatum show average of two clusters each. Colours
of bars in histograms are the same as the colours of nodes in the network
graph except for the grouped clusters. Bars below the graph indicate the
samples shown. Genes in the clusters are given in Online Resource 3. The
key to the order of samples shown in histograms is shown at the bottom of
the figure. The GEODataSet accession numbers for all samples are given
in Online Resource 1 where more information about the samples can also
be found
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phosphorylation and almost all genes had GO terms relating to
mitochondria. Human diseases included deficiencies of mito-
chondrial complexes I, II, III, IV and V. The top associated
knockout mouse phenotype was decreased embryo size, but
other phenotypes included abnormal mitochondrial physiolo-
gy and abnormal cellular respiration. Mitochondria regulate
redox signalling, which then regulates activity of transcription
factors involved in axis specification of the embryo [30],
which may account for the association with size. Thus
Cluster014 contains a group of genes which are involved in
mitochondrial function. Comprehensive analysis of these two
clusters of genes therefore showed that the clustering ap-
proach had grouped known genes of similar function and lo-
cation, confirming the validity of our clustering approach.
Distinct gene expression patterns within the nervous
system
Large-scale proteomic and gene expression analysis studies
have highlighted cell type-specific gene expression and re-
gional diversity in the mammalian brain [31, 32].We therefore
analysed all clusters of genes with high expression in various
Table 1 Summary of phenotypic information for genes identified in each cluster
Cell/tissue type Description Cluster No.
Genes
No. Genes with KO
mouse models
Top phenotype (p value) No. Genes with
human diseases
Nervous system General 5 144 72 Abnormal synaptic transmission
(3.53 × 10−26)
28
30 67 37 Abnormal nervous system physiology
(1.20 × 10−17)
10
53 19 7 Abnormal behavioural response to alcohol
(3.85 × 10−5)
8
60 21 11 Abnormal neuron physiology (0.001046) 3
73 17 6 Abnormal CNS synaptic transmission
(1.61 × 10−9)
0
77 19 6 3
Variable 59 26 12 Abnormal nervous system physiology
(3.1 × 10−6)
1
89 18 6 Increased circulating gastrin level
(4.51 × 10−5)
0
99 13 8 3
Neurons Isolated neurons
and lung
48 31 19 Abnormal vascular development
(2.30 × 10−25)
7
Isolated neurons 45 37 23 Increased systemic arterial blood pressure
(2.28 × 10−6)
8
Glia Astrocytes 6 132 70 Nervous system phenotype (2.11 × 10−7) 24
Oligodendrocytes 35 50 26 Abnormal myelination (9.54 × 10−9) 3
Microglia 85 21 10 Abnormal immune system physiology
(6.34 × 10−14)
7
Nervous system
regions
DRG 27 60 31 Abnormal touch/nociception (7.98 × 10−21) 13
66 19 5 2
88 12 3 0
Cerebellum 37 45 26 Nervous system phenotype (8.0 × 10−10) 6
56 18 6 Abnormal CNS synaptic transmission
(1.96 × 10−8)
4
Nucleus
accumbens
42 39 19 Abnormal behaviour (1.70 × 10−12) 5
96 14 7 Decreased susceptibility to diet-induced
obesity (0.000936)
4
Spinal cord 90 13 6 4
Olfactory bulb 82 18 7 Abnormal facial nerve morphology
(0.001383)
0
Myelin Synthesis 91 8 4 Impaired coordination (0.000315) 1
Other Testis 1 1627 288 Abnormal male reproductive system
physiology (2.16 × 10−125)
103
Mitochondria 14 87 10 Decreased embryo size (0.000874156) 32
Neurogenetics
nervous system tissues and cell types with the overall aim of
identifying genes with minimal functional annotation but sim-
ilar pattern of expression to known genes. Twenty-four clus-
ters of genes were chosen for detailed analysis based on the
following criteria:
1. The cluster contained at least eight unique genes (to pro-
vide adequate power);
2. The cluster genes were expressed in specific brain re-
gions, neuronal tissue or glia cell types.
Six clusters contained genes highly expressed across neu-
ronal tissues and a further three contained genes expressed at
variable levels across the neuronal tissues. These clusters were
located close to each other in the network graph, highlighting
the similarity of their expression patterns (Fig. 1b). Many
additional clusters contained genes with high expression in a
specific brain region (dorsal root ganglia, nucleus accumbens
and dorsal striatum, spinal cord and cerebellum). These clus-
ters were located close to the more general neuronal clusters
(more similar expression pattern) but distinct from them in the
network graph. Other clusters of genes showed high expres-
sion in a single cell type (astrocytes, oligodendrocytes, mi-
croglia and isolated neurons) and were located in regions dis-
tinct from others in the analysis. We also identified one cluster
of genes with high expression in both neurons and lung. In the
network graph, this group was located close to the neuron
cluster (Fig. 1b).
Functions of coexpressed neuronal genes
We initially focused on Cluster005, the largest neuronal clus-
ter. Cluster005 contained 144 genes, many encoding proteins
known to be related to neuronal function, including the
neuron-specific gene Eno2 (enolase 2, gamma, neuronal)
which functions in the glycolytic pathway and is used as a
marker for neurons [33, 34]. Other genes in this cluster includ-
ed neurotransmitter receptor components and microtubule-
and synaptosome-associated proteins, with a strong represen-
tation of genes encoding proteins involved in the function of
the synapse, which is increasingly accepted as key to neuronal
health [35]. The genes are shown in Online Resource 3. IPA
identified canonical pathways associated with signalling at the
synapse (including Huntington’s disease signalling and reelin,
GNRH, CDK5 and glutamate receptor signalling) and the top
associated networks were cell-to-cell signalling and interac-
tion, nervous system development and function and cellular
assembly and organisation. Human disease phenotypes in-
cluded autism, epilepsy and neurodegenerative disease, while
the top associated knockout mouse phenotype was abnormal
synaptic transmission. Human andmouse diseases are listed in
Online Resources 4 and 5, respectively. Recent developments
have highlighted the synapse as an early target in a broad
range of neurodegenerative diseases occurring prior to neuro-
nal pathology [35]. This largest neuronal cluster showing con-
sistent and specific phenotypes associated with synapse func-
tion highlights the importance of the synapse in neuronal
health and disease.
Five additional clusters were identified with general ex-
pression within neurons (Cluster030, 053, 060, 073 and
077). In total, these clusters contained 143 genes (Online
Resource 3), all associated with cellular signalling: neuropath-
ic pain signalling in dorsal horn neurons, (Cluster030), GABA
receptor signalling (Cluster053), clathrin-mediated endocyto-
sis signalling (Cluster060), nNOS signalling in neurons
(Cluster073) and CDP-diacylglycerol biosynthesis I
(Cluster077). Human diseases associated with these genes
were most often forms of epilepsy but also mental retardation,
spinocerebellar ataxia, Charcot-Marie-Tooth disease and spas-
tic paraplegia (Online Resource 4). Knockout mouse models
showed phenotypes including abnormal nervous system phys-
iology, abnormal behavioural response to alcohol, abnormal
neuron physiology and abnormal CNS synaptic transmission
(Online Resource 5). There were also three clusters with var-
iable expression within neuronal tissues (Cluster059, 089 and
099). IPA showed that these clusters were also all associated
with signalling pathways (glutamate receptor, JAK/Stat and
GABA receptor signalling). The top phenotypes in mouse
models were abnormal nervous system physiology, increased
circulating gastrin level and abnormalities of nerve conduc-
tion, synapses, neurodegeneration or body size. These eight
clusters were all associated with neuronal signalling,
emphasising the necessity of electrochemical signal transmis-
sion in maintaining neuronal health and viability.
Functions of genes expressed in glial cell types:
Cluster006, 035 and 085
In addition to neurons, the central nervous system also con-
tains non-neuronal glial cell types. These were originally
thought to provide ‘support’ to the neurons but are now seen
to have critical roles in neuronal development and function
[36, 37]. Glial cells have individual distinct gene profiles with
astrocytes and oligodendrocytes having a transcriptome as
diverse as that of neurons [15]. As a result, we included dif-
ferent glial cell types in our analysis (astrocytes, oligodendro-
cytes and microglia) and identified distinct clusters of genes
associated with high expression in each of these cell types.
Cluster006 contained genes strongly expressed in as-
trocytes, including glial fibrillary acidic protein (Gfap),
ion channel genes, solute carrier genes, dystrophin-
related genes, ATPase genes and ubiquitin-specific pepti-
dase. The major associated network function identified
using IPA was glutamate receptor signalling, reflecting
the role astrocytes play in glutamate clearance [38].
Neurological phenotypes such as migraine, deafness and
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ataxia were associated with mutations in these genes in
humans (Online Resource 4). Knockout mouse pheno-
types included nervous system phenotype and abnormal
nervous system physiology (Online Resource 5). Recent
studies have identified roles for astrocytes in synaptic
transmission modulation, regulation of cerebral blood
flow and release of ‘gliotransmitters’. Like microglia, they
are involved in reactive gliosis. The association of genes
in this cluster with neurological phenotypes highlights the
wide array of functions astrocytes contribute to neuronal
stability [39].
Cluster035 contained genes strongly expressed in
oligodendroctyes including Mag (encoding myelin-
associated glycoprotein), Mobp (encoding myelin-
associated oligodendrocyte basic protein) and Myrf
(encoding myelin regulatory factor) reflecting the role that
oligodendrocytes play in the generation of central nervous
system myelin. IPA analysis revealed the top canonical
pa thway to be axonal guidance s igna l l ing and
Cluster035 contained three members of the semaphorin
gene family involved in oligodendrocyte guidance during
development [40], including the oligodendrocyte-specific
semaphorin, Sema5a [41]. Human genes were associated
with spastic paraplegia and age-related macular degener-
ation. Unsurprisingly, the top associated mouse knockout
phenotype was abnormal myelination. In addition, we
identified a small cluster of genes linked to myelin syn-
thesis (Cluster 091) with high expression in oligodendro-
cytes and spinal cord and moderate expression in various
brain regions. Within this cluster, knockout mouse models
have been reported with the top associated canonical phe-
notype being impaired coordination. IPA identified the top
canonical pathway for Cluster091 to be remodelling of
epithelial adherens junctions, an intriguing finding given
the role of E-cadherin in Schwann cell myelination [42].
Details are available in Online Resources 3, 4 and 5.
Cluster085 contained genes strongly expressed in microg-
lia, with much lower expression in other macrophage lineages,
including many cytokine genes, such as Il10 and Marco
(encoding macrophage receptor with collagenous structure).
The majority of human diseases associated with these genes
impact on the immune system, reflecting the role microglia
play in the immune response. The top affected system in
mouse knockouts was abnormal immune system physiology
(including inflammation of specific organs, abnormal cyto-
kine level and abnormal response to infection). Microglia
are the macrophages of the CNS with a functional role in both
development and maintenance of the central nervous system
and recent studies have highlighted additional roles including
synaptic pruning during development [43]. Microglia underlie
different neurodegenerative disease processes, including
l ipomembranous osteodysplas ia wi th sc leros ing
leukoencephalopathy (Nasu-Hakola disease) caused by
mutations in TREM2 and adult onset leukoencephalopathy
with axonal spheroids and pigmented glia due to CSF1R
haploinsufficiency (reviewed in [44]). These genes were
found in a broader macrophage cluster.
Differential functions of genes expressed in specific
regions of the nervous system
Different regions of the mammalian brain have different mo-
tor, sensory and cognitive functions, and it is therefore not
surprising that previous genome-wide expression studies have
identified regional expression gene signatures with the cere-
bellum showing the greatest diversity [4, 45]. We therefore
expanded our analysis to clusters of genes that showed high
expression within specific brain regions. Biolayout Express3D
identified three clusters associated with the dorsal root gangli-
on (DRG; Cluster027, 066 and 088). The largest of these
clusters, Cluster027, contained the protocadherin alpha gene
cluster and genes encoding cation channels, peripherin (Prph),
peripheral myelin protein 2 (Pmp2) and the DRG homeobox
gene (Prrxl1). The top associated mouse phenotype was ab-
normal touch/nociception. A smaller cluster, Cluster066,
contained genes encoding MAP proteins (microtubule associ-
ated proteins) such asMap1b which is expressed in the DRG
during spinal cord development and regeneration [46] with
IPA identifying the top pathway to be axonal guidance signal-
ling. Interestingly axonal guidance signalling has now been
shown to be important in the mature CNS in the regulation of
synaptic activity and neuronal plasticity [47].
Two clusters were associated with high gene expression in
the cerebellum (Cluster037 and 056). Genes in Cluster037
included the amyotrophic lateral sclerosis gene (Als2) and
the top IPA pathway was glutamate receptor signalling. The
top associated murine phenotype was nervous system pheno-
type. Cluster056 contained the cadherin gene Cdh7, previous-
ly shown to modulate connectivity of mossy fibres in the
cerebellum [48] and cation channel genes. The top canonical
pathwaywas stimulatory G protein (Gs) signalling and knock-
out mouse models showed defects in CNS synaptic
transmission.
Two clusters were associated with high expression in the
nucleus accumbens and dorsal striatum (Clusters042 and 096)
functioning in reward and decision making. The top IPA path-
ways were Gs signalling (Cluster042) and GABA receptor
signalling (Cluster096) both functioning in neurotransmitter
release and reward processing; for example, dopamine binds
to a G protein-coupled receptor for Gs signalling. Phenotypes
found in knockoutmice included abnormal behaviour and obe-
sity and energy expenditure. One small cluster (Cluster090)
contained genes strongly expressed in the spinal cord and adult
brain, including the genes for myelin oligodendrocyte glyco-
protein (Mog) and the synaptobrevin protein (Vamp1). The top
canonical pathway was serotonin receptor signalling,
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associated with development and regeneration of spinal motor
neurons [49]. Cluster082 was associated with high expression
in olfactory bulb. The top canonical pathway was G protein
signalling mediated by the Tubby family of proteins, which
play a major role during development and post-differentiation
of neuronal cells (reviewed in [50]), and the top phenotype in
knockout mice was abnormal facial nerve morphology.
One cluster contained genes that were highly expressed in
isolated neurons (Cluster045). IPA identified the top canonical
pathway to be hypoxia signalling in the cardiovascular sys-
tem. Cluster045 genes have been associated with stroke, hy-
pertension and Alzheimer’s disease in humans. The top phe-
notype in knockout mouse models was increased systemic
arterial blood pressure indicating the importance of neuronal
factors in the regulation of blood pressure, for example,
through baroreceptors. For a further cluster of genes expressed
within both neurons and lung (Cluster048), IPA identified the
top pathway to be STAT3 signalling. Genes within this cluster
includedNdnf (neuron-derived neurotrophic factor) which has
high messenger RNA (mRNA) expression in human lung
(http://www.gtexportal.org/home/gene/NDNF) and is
upregulated upon ischemia [51]. Human diseases included
basal ganglia calcification and venous malformations. The
top phenotype for knockout mouse models was abnormal
vascular development. Both clusters were also enriched for
GO terms indicating extracellular localisation and
involvement in cell migration.
Tissue-specific clusters replicate in other datasets
To assess whether the clusters of genes identified as being
tissue-specific were more broadly applicable, we per-
formed two replication studies (Online Resource 2).
Firstly, we used mouse data from the FANTOM5 project,
which provides promoter level expression values across
the transcriptome. This included astrocytes from different
sources but no oligodendrocytes. The testis cluster repli-
cated well. Of 931 testis cluster genes that were annotated
in the mouse dataset, 92% were in a FANTOM5 testis
cluster. We found that the majority of annotated genes in
our neurological clusters were also in neurological clusters
in this data set. For example, 111 genes of mouse
Cluster005 (the largest nervous system cluster) were found
in the FANTOM5 dataset. Fifty-nine percent of these were
in the largest FANTOM5 neurological cluster and an ad-
ditional 26% were in another FANTOM5 cluster with ner-
vous system expression (e.g. cortex, cerebellum, olfactory
brain, etc.). The lack of oligodendrocytes and additional
region specific astrocyte samples meant that some clusters
did not replicate, as might be expected. We then looked at
a published dataset for gene expression based on microar-
rays in the pig [13] (http://biogps.org). In this dataset,
many of the neurological tissues were missing and there
were no primary glial cells (Online Resource 2). In addi-
tion, fewer genes were annotated in the pig data set so
many of the mouse genes could not be found. Again, the
testis cluster replicated well with 54% of genes (that were
found in both datasets) in the main pig testis cluster and
58% overall in clusters with testis specific expression. In
addition, 18% of the genes from the mouse testis cluster
were found in a pig fallopian tube cluster. Sixty-six per-
cent of the genes from the mouse Cluster005 that could be
found in the pig dataset were in the pig cortex cluster
while others were in the spinal cord and cerebellum clus-
ters. In addition, 67% of genes in mouse cluster 30 (ner-
vous system) were also in the pig cortex cluster. Given the
limited tissue sets available for the pig and the differences
in annotation and naming conventions between pig and
mouse, with many more unannotated pig genes, this result
shows a reassuring level of concordance and we believe
validates the clustering approach as a means to find genes
with shared expression patterns and hence assign function
to unannotated genes.
The level of annotation for genes within expression pattern
clusters varies
In addition to identifying well-annotated genes within the
characterized expression clusters of the nervous system, we
also identified genes that had little or no annotation in the most
recent Affymetrix annotation file (October 2014), no mouse
model and no associated human disease, and therefore were
not represented in IPA pathway analysis. Some of the unan-
notated genes were identified as Affymetrix probe sets that
had not been associated with a transcript; others were from
the RIKEN curated set of complementary DNAs (cDNAs)
[52] and no function or homology had been determined.
There were also poorly annotated genes that encoded a recog-
nized protein domain, but the specific function was not
known. We utilized the gene ontology (GO) terms to examine
the extent of gene annotation for all the clusters discussed
above. Table 2 and Fig. 2a show a weighted annotation score
for each cluster. Some clusters contained a high number of
well-annotated genes, while others had many unannotated
and minimally annotated genes. There was no association
with cluster size since both the largest cluster (Cluster001)
and some of the smaller clusters (for example Cluster088)
were poorly annotated while other large clusters (for example,
Cluster005) and small clusters (for example, Cluster091) were
well annotated (Fig. 2b). All genes within the mitochondrial
Cluster014 showed some degree of annotation, whereas one
third of the genes in the testis Cluster001 had no GO term
annotation. The clusters based on the nervous system showed
variable degrees of annotation with the neuronal clusters well
annotated and some of the region-specific clusters (cerebel-
lum, dorsal root ganglia) poorly annotated.
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Cluster analysis allows functional annotation to be
attributed to unannotated genes
Online Resource 6 lists the unannotated and poorly annotated
genes of the nervous system clusters discussed above. The
presence of a gene or transcript in a cluster indicates that its
expression pattern is similar to those of other genes in the
cluster and so its function is likely to be similar (‘guilt by
association’ [9]). Therefore, the clustering process yielded
further insight into function of the poorly annotated genes
and this was validated by recent publications in some cases.
Some examples are given below. For Cluster005, 17 genes
had no or minimal (one GO category only) annotation.
Expression of 2900011O08Rik (recently renamed Minp, mi-
gration inhibitory protein) has been detected specifically in the
central and peripheral nervous system and enriched in the
cerebral cortex. Knockdown ofMINP protein in mouse result-
ed in accelerated radial migration and altered microtubule
stability [53]. Gdap1l1 showed minimal annotation and has
previously only been linked to protein binding. Mutations in a
similar human gene (GDAP1) cause Charcot-Marie-Tooth
type 4A [54, 55], and this plus the result with mouse
Gdap1l1 suggests that human GDAP1L1 is a candidate for
neuromuscular disease. Despite having only one GO term,
Vsnl1 has been identified as a biomarker of Alzheimer disease
in cerebrospinal fluid [56]. A830039N20Rik is unannotated
with no associated GO terms. Analysis of gene expression in
E15 stage mouse embryos identified expression in the devel-
oping brain/nervous system and visual system (retina inner
and outer nuclear layers) by RNA in situ hybridisation
(http://www.informatics.jax.org/marker/MGI:2445176).
There are also several examples of genes with very minimal
annotation, for example; Tmem151a and Tmem179
(C14orf90) which have the attributed GO cellular component
term Bmembrane^. Both show nervous system expression by
RNA in situ hybridization according to the Jax database
Table 2 Degree of annotation for genes within each cluster
Cluster
number
Description N(0) N(1) N (2) N (3) N
(genes)
Score
(weighted)
%
(0)
%
(1)
%
(2)
%
(3)
1 Testis 541 236 212 639 1628 1.58 33 14 13 39
5 Nervous system—general 5 12 14 113 144 2.63 3 8 10 78
6 Nervous system—astrocytes 11 8 17 96 132 2.50 8 6 13 73
14 Mitochondria 0 6 15 66 87 2.69 0 7 17 76
27 Nervous system—dorsal root ganglia 3 4 5 48 60 2.63 5 7 8 80
30 Nervous system—neurons 7 5 7 48 67 2.43 10 7 10 72
35 Nervous system—oligodendrocytes 7 4 6 33 50 2.30 14 8 12 66
37 Nervous system—cerebellum 12 0 4 29 45 2.11 27 0 9 64
42 Nervous system—nucleus accumbens, dorsal
striatum
8 2 3 26 39 2.21 21 5 8 67
45 Nervous system—neurons 3 0 2 32 37 2.70 8 0 5 86
48 Neurons and lung 1 6 3 21 31 2.42 3 19 10 68
53 Nervous system—neurons 1 5 0 13 19 2.32 5 26 0 68
56 Nervous system—cerebellum, other 6 1 1 10 18 1.83 33 6 6 56
59 Nervous system—neurons 0 1 2 23 26 2.85 0 4 8 88
60 Nervous system—neurons 1 1 2 17 21 2.67 5 5 10 81
66 Nervous system—neurons, dorsal root ganglia 0 3 7 9 19 2.32 0 16 37 47
73 Nervous system—neurons 3 2 1 11 17 2.18 18 12 6 65
77 Nervous system—neurons 1 2 5 11 19 2.37 5 11 26 58
82 Olfactory bulb 3 1 1 13 18 2.33 17 6 6 72
85 Nervous system—microglia 1 1 1 18 21 2.71 5 5 5 86
88 Nervous system—dorsal root ganglia, other 4 3 0 5 12 1.50 33 25 0 42
89 Nervous system—neurons 3 1 2 12 18 2.28 17 6 11 67
90 Nervous system—spinal cord, adult brain 2 0 0 11 13 2.54 15 0 0 85
91 Nervous system—myelin synthesis 0 1 0 7 8 2.75 0 13 0 88
96 Nervous system—nucleus accumbens, dorsal
striatum
2 3 1 8 14 2.07 14 21 7 57
99 Nervous system—neurons 1 0 4 8 13 2.46 8 0 31 62
N(0), N(1), N(2), N(3) indicates the number of genes with 0, 1, 2 or 3 associated GO terms respectively. %(0), %(1), %(2), %(3) indicates the percentage
of genes with 0, 1, 2 or 3 associated GO terms
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(http://www.informatics.jax.org/marker/MGI:2147713 and
http://www.informatics.jax.org/marker/MGI:2144891).
Clearly, the limited information available for these genes
supports their role in the nervous system which was implied
by their presence in Cluster005. There are several genes with
no annotation at al l in Cluster005; for example,
B230217C12Rik. Their presence in this cluster highlights
their potential role in nervous system form and/or function.
This also holds true for the other clusters. For example,
Cluster006 (astrocyte) contains the minimally annotated
gene Olfml1 (olfactomedin-like 1). Olfactomedin proteins
are involved in the organisation and development of the
nervous system [57]. A paralog of the Olfm gene, Gldn
(gliomedin), functions in the formation and maintenance
of nodes of Ranvier [58, 59] and the protein encoded by
this poorly annotated gene may have a similar role. A
knockout mouse model has now been made of the
Cluster056 (cerebellum) gene Frrs1l showing partial pre-
weaning lethality, limb grasping, abnormal gait, hyperac-
tivity, abnormal behaviour, trunk curl, absent vibrissae
and decreased grip strength, all neuronal phenotypes
(www.mousephenotype.org/data/genes/MGI:2442704). A
recent study showed SH2D5 protein (Sh2d5 gene in
Cluster096, nucleus accumbens and dorsal striatum) to
be highly enriched in adult mouse brain and to associate
with breakpoint cluster region protein (BCR), a regulator
of Rho GTPases which is also highly expressed in the
brain [60]. In situ hybridisation of the Cluster077
(neuronal) gene A930009E05Rik (also known as
Tmem178b) showed exclusive expression in the nervous
system (http://www.informatics.jax.org/marker/MGI:
3647581). Additionally, the Cluster073 (neuronal) gene
Ctxn1 is expressed specifically in the brain and enriched
in the cortex. In situ hybridisation reported expression in
neurons of the cerebral cortex [61].
Expression of unannotated genes in other datasets
We used four sources to validate the expression patterns of
the poorly annotated genes: the Allen Brain Atlas (in situ
hybridisation of RNA probes to C57BL/6J mouse tissues),
MGI expression data (in situ hybridisation in mouse brain),
human gene expression data from BioGPS and pig gene
expression data from BioGPS. Many of the poorly annotat-
ed genes were not found in the human and pig, as they are
identified only by mouse Ensembl IDs. Those that could be
found showed concordance in all four datasets. For exam-
ple, Fbxo41 (mouse Cluster005 nervous system) was
expressed in mouse brain regions, human brain and pig pre-
frontal cortex. Baalc (Cluster 006 Astrocytes) was expres-
sion in mouse brain regions, human brain and pig nervous
system and thyroid. The results of this validation are sum-
marized in Online Resource 7.
This highlight the benefits of this clustering analysis and
through guilt by association allows us to predict that the un-
annotated genes for which little or nothing is known will be
novel candidates for a role in maintenance of neuronal health
withmutations/perturbations in expression linked to neurolog-
ical disease.
Fig. 2 Gene ontology annotation scores for each gene cluster. a Bar
graph showing overall weighted annotation scores for the gene clusters.
Genes within each cluster were scored either 0 or 1 for each of the three
gene ontology categories (GO cellular compartment, GO biological
process, GO molecular function) depending on the absence or presence
(no matter how minimal) of GO information. An average weighed score
was calculated for each cluster (maximum score of 3 if each GO category
had an entry for each gene in the cluster). Scores ranged from 1.50
(Cluster088, dorsal root ganglion) to 2.77 (Cluster045, isolated
neurons). Clusters are shown in the order of cluster number (see
Table 2). b Scatterplot of number of genes in a cluster compared with
the weighed annotation score. The testis cluster was excluded from the
graph because it had 10 times more genes than the next cluster (total
1628); the result when testis was included was similar
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Neuronal clusters are perturbed in neurodegenerative
disease
We were interested to see the impact of a disease state on the
clusters we found. We therefore reanalysed the original sam-
ples with the addition of a dataset of adult mouse hippocam-
pus 17 weeks after exposure to theME7 prion infectious agent
(Online Resource 2). The main tissue clusters (for example,
testis, connective tissue, digestive tract) and functional clus-
ters (protein synthesis, proliferation) were retained with very
minor differences. However, genes in the original nervous
system Cluster005 were distributed to a number of other clus-
ters also showing high expression in the nervous system.
Fifty-six percent were in ME7 Cluster014 and 24% were in
ME7 Cluster055 and 057. In addition, some of the immune
cell clusters were similarly disrupted with genes distributed to
smaller clusters.
Discussion
The rapid development of technologies facilitating large-scale
genome and transcriptome analysis has led to the generation
of a vast resource of data, with the capacity to offer new
insights into the genetic organization and regulation of biolog-
ical systems in health and disease. This has been particularly
notable in the field of neurogenetics research (for examples,
see [15–18, 62–68]). In this study, we used BioLayout
Express3D [21] to interrogate publicly available databases of
genome-wide expression results in the mouse. Unlike many
other network analysis software tools, BioLayout Express3D
employs an unstructured approach to cluster genes based on
gene expression patterns across the sample set [9, 21]. It does
not incorporate pre-existing knowledge of biological path-
ways and thus is able to identify previously undocumented
relationships among genes. BioLayout Express3D enables the
user to visualize complex relationships in two and three di-
mensions and cluster genes based solely on gene expression
pattern. We were then able to identify clusters containing
highly annotated genes and infer new functions/phenotypes
of poorly annotated genes by guilt by association. Our overall
goal was to identify novel genes as candidates for a role in
nervous system health and function.
The level of a specific mRNA in a cell indicates the potential
for the cell to make the encoded protein. To validate the rela-
tionship between RNA level and phenotypic outcomemediated
by the protein product, we initially used two clusters of genes:
the largest cluster identified in our analysis, Cluster001, asso-
ciated with expression in testis, and a mitochondrial cluster
(Cluster014). We showed that both of these clusters had corre-
sponding phenotypes consistent with the expression pattern.
The testis cluster was associated with reproductive phenotypes,
including male sterility and the mitochondrial cluster was
associatedwith knownmitochondrial diseases.We also showed
a high level of replication in a different mouse data set and in a
smaller set of tissues from the pig, suggesting that the genes in
the clusters are generally highly correlated. Addition of a neu-
rodegenerative disease sample (ME7 prion infection) perturbed
the nervous system and some immunological clusters, indicat-
ing that the disease state impacts on these groups of genes and
providing potential insights into the disease process.
We then focused our analysis on distinct clusters of genes
expressed in different cell types/regions of the nervous sys-
tem. This analysis highlighted the differences between brain
regions and cell types. High expression of some genes was com-
mon to all nervous system regions (general nervous system
clusters in Table 1 and Online Resource 3). These included
genes encoding proteins of synaptic and axonal compartments
such as signalling molecules and receptor-mediated develop-
mental guidance and patterning. Several regions were found to
have specific gene expression signatures. For example, cere-
bellum was characterized by expression of genes involved in
immunological and inflammatory responses [32] while the
nucleus accumbens and dorsal striatum shared high expres-
sion of genes involved in protein kinase A signalling and
mitochondrial permeability. These gene expression signatures
were largely consistent with phenotypes generated in knock-
out mice and in humans with gene mutations. Approximately
half of the genes identified in our BioLayout Express3D anal-
ysis clusters had a characterized knockout mouse model. The
top-associated knockout mouse phenotype for the majority of
clusters was linked to the nervous system, in particular, the
synapse, reflecting the established role of the synapse in ner-
vous system form and function (reviewed in [35]). We noted
that not all clusters showed specifically neuronal phenotypes
when the genes were knocked out in the mouse. Three clusters
were enriched for behavioural phenotypes (Cluster053,
Cluster027 and Cluster042), two clusters showed vascular and
respiratory phenotypes (Cluster048 and Cluster045) and
two small clusters contained genes related to gastrin release
and obesity (Cluster089 and Cluster096). All of these can be
linked back to the nervous system. For example, the brain
controls appetite and food intake [69]. Additionally, a small
number of mouse knockouts lacked any overt phenotype,
which could be attributable to redundancy between different
members of the same gene family, exemplified by the
Cluster005 gene Brsk1. Knockout mice were viable and fertile
with no overt phenotypic abnormalities (Online Resource 5).
However, double Brsk1/Brsk2 knockout mutants showed
clear neurological phenotypes: minimal spontaneous move-
ment, weak responses to stimulation and neonatal death
[70]. Thus the role of these genes was only revealed when
both were non-functional. Our approach to validation of our
clusters has shown that generation of knockout models for
other genes in the clusters will reveal novel genes that con-
tribute significantly to neurological function.
Neurogenetics
Some markers considered definitive of specific cell types
are not present in the corresponding clusters. There are a
number of explanations for this. Firstly, many classic
antibody-based markers of cell type have different names
from the gene names. For example, the gene encoding the
microglia marker IBA1 is Aif1 in the current annotation.
Secondly, some markers used to identify microglia in the
brain are also found inmacrophages, such as F4/80 (encoded
by Emr1). Since we have several macrophage subsets in our
analysis, these genes do not fall into themicroglia cluster but
into the main macrophage clusters. Thirdly, some of these
markers have unique expression patterns, which are not cor-
related with the expression of any other gene at the threshold
correlation coefficient value used. For example, the three
Csf1r probe sets do not cluster with any other probe sets
because of the unique expression pattern of Csf1r which in-
cludes expression in placenta. Finally, if these markers have
low expression in the tissues analysed they would have been
excluded by our filtering process.
We have previously shown that the level of gene annota-
tion is associated with the intensity with which the tissue or
function has been studied, often a reflection of whether the
gene is tissue- or function-specific, when it is likely to be
well annotated, or more ubiquitous and likely to be mini-
mally annotated [9, 13]. Thus, the mitochondrial Cluster014
was well annotated, as was the myelin Cluster091 and the
clusters highly expressed in neurons. These cell types and
functions have been extensively examined for many years
and it is not surprising that most genes in these clusters are
well understood. In contrast, several clusters were poorly
annotated, including testis Cluster001, dorsal root ganglia
Cluster088 and cerebellum Cluster037 and 056. The testis
has an extensive transcriptome of approximately 20,000
genes, with many novel splice variants, alternative promot-
er usage and long non-coding RNA species (see, for exam-
ple, [71–73]). We found that one third of genes in the main
testis cluster had no annotation, consistent with this exten-
sive and novel transcriptome. The lack of annotation for the
transcriptomes in the cerebellum and dorsal root ganglia
suggests that these regions also have novel transcripts
which may be a rich source of candidate genes for neuro-
logical conditions.
Importantly, this study enabled us to identify a large subset
of genes with minimal or no GO annotation; some of which
we have shown through the MGI Jax database, the Allen
Brain Atlas, and human and pig expression data to be exclu-
sively expressed within the nervous system and others linked
to human disease. Presence of unannotated genes in a cluster
indicates an expression pattern similar to that of the genes
encoding proteins of known function in the same cluster and
suggests that these genes are highly likely to represent novel
candidates for roles in the regulation of form and/or function
of the mammalian nervous system.
Conclusions
Taken together, the phenotypes, pathways and GO term anno-
tation associated with genes expressed in distinct cell types
and region-specific clusters of the nervous system highlight
the powerful contribution of such an extensive array of genes
to the maintenance of neuronal homeostatic mechanisms.
Importantly, we identified a large number of genes in each
of the clusters which had minimal functional annotation.
From the analyses reported in this study, we can now attribute
putative functions to these poorly annotated genes, as we
know the function of the genes they co-express with. These
novel genes are likely to have important roles in regulating
form and/or function of the mammalian nervous system.
Further analysis of these genes, for example, through creating
geneticallymodifiedmice and synthesizing and characterizing
recombinant proteins, should reveal similar functions and phe-
notypes to other genes in the same cluster and consolidate
their value as candidates for human neurological disorders.
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